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Abstract
The incidence of central-line-associated bloodstream infection (CLA-BSI) is reported per 1000 days of catheter exposure, mainly in the
intensive care unit (ICU), because recording exposure throughout an institution is not always feasible. Conﬁrmation of catheter-related
bloodstream infection (CR-BSI) requires speciﬁc laboratory testing that identiﬁes the catheter as the source of infection. This informa-
tion is available in microbiology laboratories and can be assessed using a denominator of 1000 admissions. We evaluated recent trends
in the incidence and aetiology of CR-BSI and compared adult ICUs with the remaining areas of the hospital in a retrospective cohort
analysis of all conﬁrmed CR-BSIs. During the 8-year study period, we recorded 1208 episodes (8.2% of BSIs) of CR-BSI. After adjusting
for the blood cultures drawn, a signiﬁcant reduction in incidence was observed in adult ICUs (47%), where care bundles had been
applied. The reduction was similar irrespective of whether CLA-BSI or CR-BSI was assessed. We recorded a signiﬁcant reduction in the
incidence of Staphylococcus aureus CR-BSI, and a signiﬁcant increase in the incidence of CR-BSI caused by Enterococcus sp., Gram-negative
microorganisms and fungi. The microbiology department may complement CLA-BSI/1000 catheter-days by providing CR-BSI when days
of exposure are not available, because both ﬁgures are parallel. We demonstrated a signiﬁcant reduction in the incidence of CR-BSI in
recent years in the population admitted to adult ICUs but not in the remaining areas of the hospital. A shift in the aetiological spectrum
of CR-BSI may be occurring.
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Introduction
Evolution of the incidence of central-line-associated blood-
stream infection (CLA-BSI) has been assessed mainly in adult
intensive care units (ICUs) where care bundles have been
implemented in recent years [1–3]. However, a signiﬁcant
number of CLA-BSI episodes occur outside the ICU, in areas
where quality control programmes are not always imple-
mented. Information regarding the evolution of CLA-BSI
throughout an institution is scarce, probably due to the difﬁ-
culty in determining the number of days of exposure to a
catheter. Furthermore, conﬁrmation of CLA-BSI does not
require microbiological laboratory testing; therefore, the
problem may be overestimated, and infection could be attrib-
uted to other causes [4]. New and easier methods to report
hospital-wide trends are clearly required [5].
By contrast, catheter-related bloodstream infection (CR-
BSI) requires speciﬁc laboratory testing that more thoroughly
identiﬁes the catheter as the source of infection. This informa-
tion is always available in the microbiology department and
can be reported against the denominator of 1000 admissions
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or 1000 days of stay, both of which are readily available in
hospitals.
Data regarding secular trends in the incidence and aetiol-
ogy of CR-BSI in general hospitals are very scarce [6], and
most ﬁndings are biased by the selection of speciﬁc units and
patients or short study periods [7–9].
The aim of our study was to assess secular trends in the
incidence and aetiology of CR-BSI in a large general hospital
using the microbiology laboratory as a watchtower. We also
compared CR-BSI in the adult ICUs with the remaining areas
of the hospital.
Material and Methods
Our hospital is a general teaching institution serving a popula-
tion that ranged from 704 030 to 806 769 inhabitants during
the study period (January 2003–December 2010). The num-
ber of beds available decreased from 2500 to approximately
1550 during this period as a result of the opening of new pri-
mary care hospitals to absorb less complex patients. Our hos-
pital provides all the services of a general teaching hospital.
We included all blood and catheter samples sent for bacterial
and fungal culture to our laboratory during the study period.
Blood culture systems
Our institution recommends extraction of three blood sam-
ples for evaluation of all episodes of suspected bacteraemia
or fungaemia. Blood cultures were processed using BACTEC
9240 (Becton Dickinson Microbiology Systems, Maryland,
DE, USA). Methods for processing positive blood cultures
were standard [10].
Catheter cultures
In our hospital we followed CDC Guidelines for sending vas-
cular catheter tips from patients with clinical suspicion of
sepsis for culture in the Microbiology Department [4]. All
catheter tips were cultured immediately according to the
semi-quantitative roll-plate technique [11]. All microorgan-
isms present in counts ‡15 colony-forming units (CFUs)
were identiﬁed to genus and species level, and information
on antimicrobial susceptibility was recorded.
Deﬁnitions
An episode of ‘signiﬁcant’ bloodstream infection was deﬁned
as an episode of bacteraemia or fungaemia, in which those
pathogens were present in ‡1 blood cultures. We consid-
ered commensal microorganisms [coagulase negative Staphy-
lococci (CNS), Corynebacterium sp. (except C. jeikeium),
Lactobacillus sp., Bacillus sp. and Propionibacterium sp., or
viridans group Streptococcus isolates and C. perfringens] as
probable pathogens when they were recovered in ‡2 blood
cultures. In the case of neonates, due to the difﬁculty in
obtaining blood from these patients and following standard
recommendations, we accepted as signiﬁcant the presence of
CNS or other potential contaminants in both bottles of a
single venous puncture. Only the number of patients—not
the number of blood cultures—was taken into consideration.
All microorganisms isolated from blood from the same
patient within 1 week were considered a single episode.
The deﬁnitions for catheter infections are those detailed
in the Clinical Practice Guidelines for the Diagnosis and Man-
agement of Intravascular Catheter-Related Infection [4]. In
summary, CR-BSI was deﬁned as those episodes in which
the same microorganism was recovered from blood and a
catheter segment with an interval of <8 days, provided that
there was no infection at another site. Other CR-BSI epi-
sodes diagnosed by quantitative blood cultures or differential
time to positivity (DTTP) were excluded. Central-line-associ-
ated bloodstream infection (CLA-BSI) was deﬁned as having
a primary bloodstream infection (BSI) in a patient with a cen-
tral line in place within a 48-h period before onset of the BSI
that was not related to infection at another site.
Microorganisms recovered from blood or catheters were
identiﬁed using the automated MicroScan system with the
POS Combo Panel Type 2S and NEG Combo Panel Type 1S
(DADE Behring, Sacramento, CA, USA).
Implementation of catheter care bundles
In 2009, our institution joined a national programme to imple-
ment a catheter care bundle in adult ICUs, with the intention
of reaching zero incidence of CLA-BSI. This consisted of incor-
porating the following ﬁve evidence-based procedures recom-
mended by the CDC: hand hygiene, using full-barrier
precautions during the insertion of central venous catheters,
cleaning the skin with chlorhexidine, avoiding the femoral site
if possible, and removing unnecessary catheters [3].
Statistical analysis
The database of episodes of signiﬁcant BSI was prospectively
updated on a daily basis by the same member of staff of the
microbiology laboratory from the beginning of the study.
This database also included all endovascular catheters during
the study period.
The global incidence of BSI and CR-BSI is expressed as
episodes per 1000 admissions.
Overall trends in rate per month over time were adjusted
using Poisson regression analysis to estimate the incidence
rate ratio (IRR) with a 95% conﬁdence interval (95% CI)
adjusted for the number of monthly blood cultures. In order
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to analyse the evolution of our series, we estimated the IRR,
for which the reference year was 2003. Evolution of micro-
organisms was expressed as the annual IRR.
In order to compare trends in the evolution of catheter-
related infections (CLA-BSI/1000 days of exposure vs. CR-
BSI/1000 admissions), we estimated the slope in one of the
adult ICUs on which both sets of data were available
throughout the study period. The slope of annual IRR com-
pared with 2003 was adjusted using linear regression. These
slopes are presented with a 95% CI.
All analyses were performed using SPSS v.14 for Windows
e (SPSS Inc, Chicago, IL, USA) and STATA v.11.
Statistical signiﬁcance was set at p <0.05.
Ethics committee approval
This study has been approved by our local ethics committee.
Results
Correlation between CR-BSI obtained from microbiology
laboratory data and epidemiological CLA-BSI data recorded
at the bedside
Our institution had 479 710 admissions during the study period
(mean, 59 964 admissions/year). We received a total of
356 497 and 17 642 blood culture samples and catheter tips for
culture, respectively (Table 1a). The total number of signiﬁcant
episodes of BSI was 14 713 (30.67 episodes/1000 admissions).
Of these, 1208 episodes (8.2%) had a simultaneous catheter
with a positive culture with the same microorganism and were
considered CR-BSI. The remaining 13 505 BSI episodes were
those without concomitant or negative catheter tip cultures.
The incidence of CR-BSI ranged from 1.9 to 3.6 episodes/1000
admissions (mean, 2.5 episodes/1000 admissions). As for loca-
tion, 35.5% of CR-BSIs occurred in adult ICUs, 27% in paediat-
ric ICUs, and the remaining 37.5% occurred in other units.
When data were analysed on a monthly basis, we
detected signiﬁcant variations in CR-BSI from month to
month. However, no signiﬁcant overall reduction in the
adjusted incidence of CR-BSI was detected from the begin-
ning to the end of the study period (p 0.598) (Fig. 1a).
We compared trends in the incidence of CR-BSI in adult
ICUs with those for other departments (Table 1b). In adult
ICUs, the IRR was 45% after adjusting for the number of
blood cultures drawn (95% CI, 15–65%; p 0.007). In the
remaining areas of the institution, where care bundles had
not been implemented, there were no signiﬁcant differences
from the 2003 reference values (Fig. 1b).
In order to assess the parallelism between CLA-BSI/
1000 days of exposure and CR-BSI/1000 admissions, we
TABLE 1. Evolution of CR-BSI during the study period
(a) Global data
Year Overall admissions
Total BSI
(per 1000
admissions)
Episodes of BSI
without concomitant
or negative TC
(per 1000 admissions)
No. of
received BCs
No. of
received CTs
2003 54 781 1613 (29.44) 26.69 38 796 2143
2004 61 299 1642 (26.79) 24.91 40 713 2406
2005 62 773 1773 (28.24) 25.95 44 187 2399
2006 65 681 2040 (31.06) 28.78 47 101 2044
2007 67 882 2232 (32.88) 30.49 51 753 1910
2008 58 724 1944 (33.10) 30.38 47 338 1815
2009 53 433 1825 (34.15) 30.60 46 659 2545
2010 55 137 1644 (29.82) 27.35 39 950 2380
Total (annual average) 479 710 (59 964) 14 713 (30.67) 28.14 356 497 17 642
(b) Speciﬁc data
Year
Episodes of CR-BSI
(per 1000 admissions) % CR-BSI
Adult ICUs All other units
Admissions
Episodes of CR-BSI
(per 1000 admissions) Admissions
Episodes of CR-BSI
(per 1000 admissions)
2003 151 (2.8) 9.4 3538 51 (14.41) 51 243 100 (1.95)
2004 115 (1.9) 7.0 3629 40 (11.02) 57 670 75 (1.30)
2005 144 (2.3) 8.1 3760 46 (12.23) 59 013 98 (.66)
2006 150 (2.3) 7.4 3995 74 (18.52) 61 686 76 (1.23)
2007 162 (2.4) 7.3 3959 63 (15.91) 63 923 98 (1.55)
2008 160 (2.7) 8.2 3928 49 (12.47) 54 796 111 (2.03)
2009 190 (3.6) 10.4 3726 71 (19.06) 49 707 119 (2.39)
2010 136 (2.5) 8.3 3706 36 (9.71) 51 431 101 (1.94)
Total (annual average) 1208 (2.5) 8.2 30 241 (3780) 430 (14.22) 449 462 (56 183) 778 (1.73)
BSI, bloodstream infections; BCs, blood cultures; TC, tip culture; CTs, catheters; CR-BSI, catheter-related bloodstream infection; ICUs, intensive care units.
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selected an ICU in which the monthly CLA-BSI data were
available throughout the study period. The correlation
between both methods of assessment showed clear parallel-
ism, with a slope of episodes/1000 admissions of 0.92 (95%
CI, 0.84–1.00; p 0.046) for CR-BSI vs. a slope of 0.91 (95%
CI, 0.83–0.99; p 0.055) for CLA-BSI. The comparison
between both IRR graphs also showed no statistically signiﬁ-
cant differences (p 0.879) (Fig. 2).
Aetiology and evolution of CR-BSI
During the study period, 1255 microorganisms from 1208
episodes of CR-BSI were identiﬁed from blood and catheter
tips simultaneously.
CR-BSI was caused by Gram-positive bacteria in 67% of
episodes, and the remaining episodes were caused by aerobic
or facultative Gram-negative bacteria (17%) and fungi (16%).
The evolution of the incidence of different microorganisms
throughout the study period is represented in Table 2 and
Fig. 3.
Our data show a 25% overall reduction in the incidence of
Gram-positive agents (831 episodes) when 2010 is compared
with the reference year of 2003 (95% CI, 1–44%; p 0.04).
The mean annual incidence of Gram-negative CR-BSI in
our institution was 0.44 episodes/1000 admissions, with a sig-
niﬁcant increase of 8.9% per year (95% CI, 2.6–15.7%;
p 0.005).
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FIG. 1. (a) Evolution of the incidence
rate ratio of microbiologically conﬁrmed
CR-BSI/1000 admissions. (b) Evolution
of incidence rate ratio of the CR-BSI/
1000 admissions in adult ICUs com-
pared with the remaining hospital units.
Ad, admissions; ICUs, intensive care
units.
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Episodes of fungal CR-BSI and the associated trends
during the study period are summarized in Fig. 3. The inci-
dence increased progressively from 2003 to 2010 at an
annual rate of 14% (95% CI, 6–21%; p <0.001).
Discussion
Our results show that the microbiology department could
prove to be an excellent complementary watchtower for
monitoring the incidence and aetiology of CR-BSI in hospitals
or units where collection of days of catheter exposure is not
feasible. We demonstrated a signiﬁcant reduction in the inci-
dence of CR-BSI in patients admitted to adult ICUs, but not
in the remaining hospital areas. We also observed a poten-
tially ongoing shift in the aetiological spectrum of CR-BSI,
with a progressive decrease in the incidence of Gram-posi-
tive CR-BSI and a signiﬁcant increase in that of Gram-nega-
tive agents and Candida.
CLA-BSI is a major healthcare problem that is associated
with signiﬁcant morbidity and mortality and increases in
costs [4,12–14]. There are few data on secular trends in the
incidence of this infection [6].
Moreover, data regarding the role of the microbiologist in
monitoring CR-BSI trends are scarce. It has been recently
reported that conducting surveillance for CLA-BSI by labora-
tory-based methods was better than it being carried out by
infection preventionists [15].
The most common way to report CLA-BSI is as incidence
density associated with days/patient of vascular catheter expo-
sure. Using this denominator is common practice in most ICUs,
although it is more difﬁcult to assess for the whole population
TABLE 2. Evolution of the incidence of microorganisms during the study period
N (incidence per
1000 admissions)
Year
2003 2004 2005 2006 2007 2008 2009 2010 Total
Gram (+) 117 (2.14) 90 (1.47) 106 (1.69) 91 (1.39) 105 (1.55) 101 (1.72) 133 (2.49) 88 (1.60) 831 (1.73)
CoNS 65 (1.19) 57 (0.93) 70 (1.12) 61 (0.93) 63 (0.94) 70 (1.19) 87 (1.63) 60 (1.09) 534 (1.11)
S. aureus 45 (0.82) 30 (0.49) 22 (0.35) 23 (0.35) 31 (0.46) 20 (0.34) 24 (0.45) 18 (0.33) 213 (0.44)
MS S. aureus 21 (0.38) 13 (0.21) 13 (0.21) 9 (0.14) 11 (0.16) 9 (0.15) 17 (0.32) 9 (0.16) 102 (0.21)
MR S. aureus 24 (0.44) 17 (0.28) 9 (0.14) 14 (0.21) 20 (0.29) 11 (0.19) 7 (0.13) 9 (0.16) 111 (0.23)
Enterococcus spp. 5 (0.09) 3 (0.05) 15 (0.24) 5 (0.08) 9 (0.13) 9 (0.15) 21 (0.39) 12 (0.22) 79 (0.16)
Other 3 (0.054) 0 2 (0.031) 3 (0.045) 2 (0.029) 3 (0.051) 2 (0.037) 1 (0.018) 16 (0.033)
Gram ()) 18 (0.33) 15 (0.24) 31 (0.49) 33 (0.50) 23 (0.34) 27 (0.46) 35 (0.66) 27 (0.49) 209 (0.44)
E. coli 1 (0.02) 4 (0.07) 3 (0.05) 1 (0.02) 2 (0.03) 9 (0.15) 6 (0.07) 3 (0.05) 29 (0.06)
Klebsiella spp. 2 (0.04) 5 (0.08) 7 (0.11) 7 (0.11) 5 (0.07) 3 (0.05) 4 (0.07) 7 (0.13) 40 (0.08)
Enterobacter spp. 7 (0.13) 2 (0.03) 2 (0.03) 8 (0.12) 6 (0.09) 7 (0.12) 5 (0.09) 2 (0.04) 39 (0.08)
Serratia spp. 3 (0.05) 1 (0.02) 7 (0.11) 4 (0.06) 4 (0.06) 1 (0.02) 2 (0.04) 3 (0.05) 25 (0.05)
Proteus spp. 0 2 (0.03) 0 3 (0.05) 0 1 (0.02) 3 (0.06) 4 (0.07) 13 (0.03)
Pseudomonas spp. 4 (0.07) 0 6 (0.010) 5 (0.08) 3 (0.04) 3 (0.05) 9 (0.17) 5 (0.09) 35 (0.07)
Yeasts 15 (0.27) 13 (0.21) 12 (0.19) 28 (0.43) 37 (0.55) 34 (0.58) 29 (0.54) 26 (0.47) 194 (0.40)
Candida 14 (0.26) 13 (0.21) 12 (0.19) 27 (0.41) 37 (0.55) 34 (0.58) 27 (0.51) 26 (0.47) 190 (0.40)
C. albicans 5 (0.09) 3 (0.05) 5 (0.08) 10 (0.15) 19 (0.28) 11 (0.19) 14 (0.26) 16 (0.29) 83 (0.17)
C. parapsilosis 6 (0.11) 8 (0.13) 7 (0.11) 15 (0.23) 14 (0.21) 15 (0.26) 10 (0.19) 5 (0.09) 80 (0.17)
C. glabrata 1 (0.02) 2 (0.03) 0 0 2 (0.03) 3 (0.05) 2 (0.04) 3 (0.05) 13 (0.03)
C. tropicalis 2 (0.04) 0 0 1 (0.02) 1 (0.01) 3 (0.05) 1 (0.02) 1 (0.02) 9 (0.02)
CoNS, coagulase-negative staphylococci; MS, methicillin susceptible; MR, methicillin resistant.
p = 0.04 
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of a general hospital [16]. In contrast, CR-BSI requires microbi-
ological conﬁrmation of origin in a colonized catheter [4].
Continuous monitoring of CR-BSI in non-ICU areas is
essential, although assessment of the days of exposure to cath-
eters in a large hospital is not always feasible [6]. We are not
suggesting that CLA-BSI be replaced by CR-BSI, because we
are convinced of the utility of incidence density determination.
We merely stress that, where monitoring of catheter days is
not feasible, CR-BSI may be used as a complementary proce-
dure to estimate bloodstream infections related to catheters
in a whole institution based on the number of admissions or
other available denominators. We chose number of admis-
sions as our denominator because it was easier to obtain than
number of patient days, which is submitted to political and
administrative pressures for reducing hospital days. Moreover,
when the denominator was patient days we obtained a parallel
graph to that of admissions (see Supporting Information). Such
an approach would allow benchmarking of larger areas of the
hospital, thus extending the possibility of implementing cathe-
ter-care bundles in non-ICU units.
Future studies comparing CLA-BSI/1000 days with CR-BSI/
1000 admissions should clarify the relationship between these
ﬁgures. We compared secular trends in the incidence of CLA-
BSI and CR-BSI in one of our adult ICUs and found a good
correlation between both parameters, namely, a decrease in
incidence. The closeness of both curves is justiﬁed by the char-
acteristics of most ICUs, in which the number of device-days is
almost equal to the number of patient-days.
Our study also points to a shift in the aetiological spectrum
of CR-BSI in recent years. Reports on recent trends in the
aetiology of CR-BSI are scarce [6] and usually refer to particu-
lar types of patients or speciﬁc types of catheters [17–22]. In
our institution, Gram-positive agents continue to be the main
cause of CR-BSI; however, a signiﬁcant reduction in the inci-
dence of S. aureus was observed during the study period. We
believe that the infection control measures for MRSA intro-
duced in 2004 may partially explain this evolution. In contrast,
Enterococcus spp. seems to be an emerging cause of CR-BSI,
and its incidence is increasing signiﬁcantly [23].
A change in the epidemiology of central venous catheter-
related bloodstream infections, with increasing prevalence of
Gram-negative pathogens, has already been reported
[6,21,24]. We found an increased incidence of Gram-negative
CR-BSI in recent years in an unselected population in a large
hospital.
The role of Candida spp. and other yeasts as a cause of CR-
BSI is becoming more evident [25,26]. In our institution, the
incidence of fungal CR-BSI more than doubled during the study
period. Probably the increasing complexity of our patients
could explain this, because neither a new haematology-oncol-
ogy ward nor bone marrow transplantation unit was created,
nor was a change of antibiotic recommendations introduced.
Our study is limited in that data were collected in a single
institution and may not necessarily be extrapolated to other
centres. The approach we applied would be impossible in insti-
tutions that do not perform catheter cultures and that only
rely on DTTP. Regarding this issue, as we did not include the
CR-BSI episodes that were only detected by DTTP, we missed
406 episodes from 2005 to 2010. Moreover, in hospitals with
large cohorts of patients with long-term catheters, the infec-
tion rates per 1000 patients would be much higher than the
BSI rates per 1000 catheter-days. Another limitation was that
some variables associated with CLA-BSI, such as APACHE
score and catheter site, were not controlled. Finally, using a
patient denominator may not take account of changes in
device-days, and this possibility would have to be monitored in
units where both ﬁgures are available, such as ICUs. However,
we believe that this potential drawback is outweighed by the
beneﬁt of having sequential ﬁgures of catheter infection in
areas where catheter-days are neither routinely collected nor
feasibly obtained on a regular basis.
In summary, our data suggest that the microbiology
department can provide data on CR-BSI from blood culture
and catheter tip records. These data can complement CLA-
BSI reports from ICUs and provide a hospital-wide view of
the problem. We detected a shift in the aetiological spec-
trum of CR-BSI, which may have implications for empirical
therapeutic decisions.
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